Low T3 syndrome is a strong predictor of poor outcomes in patients with community-acquired pneumonia

Citations Over TimeTop 10% of 2016 papers

Abstract

Low T3 syndrome was previously reported to be linked to poor clinical outcomes in critically ill patients. The aim of this study was to evaluate the predictive power of low T3 syndrome for clinical outcomes in patients with community-acquired pneumonia (CAP). Data for 503 patients were analyzed retrospectively, and the primary end point was 30-day mortality. The intensive care unit (ICU) admission rate and 30-day mortality were 8.3% and 6.4% respectively. The prevalence of low T3 syndrome differed significantly between survivors and nonsurvivors (29.1% vs 71.9%, P < 0.001), and low T3 syndrome was associated with a remarkable increased risk of 30-day mortality and ICU admission in patients with severe CAP. Multivariate logistic regression analysis produced an odds ratio of 2.96 (95% CI 1.14-7.76, P = 0.025) for 30-day mortality in CAP patients with low T3 syndrome. Survival analysis revealed that the survival rate among CAP patients with low T3 syndrome was lower than that in the control group (P < 0.01). Adding low T3 syndrome to the PSI and CURB-65 significantly increased the areas under the ROC curves for predicting ICU admission and 30-day mortality. In conclusion, low T3 syndrome is an independent risk factor for 30-day mortality in CAP patients.

Related Papers

• → Community acquired pneumonia: assessment and treatment(2012)15 cited
• → Hospital-acquired pneumonia and community-acquired pneumonia: two guys?(2016)8 cited
• → THE STATE OF THE PROOXIDANT-ANTIOXIDANT BLOOD SYSTEM IN CHILDREN WITH COMMUNITY-ACQUIRED PNEUMONIA(2023)1 cited
• [Community-acquired pneumonia caused by biological pathogens].(2012)
• → Assement of Severity of Community Acquired Pneumonia By CURB-65(2019)